Analysis was performed using soluble fractions isolated from brains using a method described previously [105]. Briefly, brain tissue was homogenized in Triton lysis buffer containing the following: 50 mM Tris–HCl (H 7.5), 150 mM NaCl, 10 mM NaF, 0.5% Triton X-100, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 2 μg/mL leupeptin, aprotinin and protease inhibitor cocktail. Homogenates were then centrifuged at 14,000 rpm for 1 hr at 4 °C. The supernatants were collected and the concentration of protein in lysates was measured using standard techniques (Pierce 660-nm protein assay reagent, Thermo Scientific, Rockford, IL, USA). Protein (20 µg) from each fraction was resolved by SDS–PAGE and transferred onto polyvinylidene difluoride membranes. Antibodies against BACE-1, A11, tau, MC-1, PARP, GFAP, BDNF, NGF, synaptophysin, PSD-95, caspase (3, 7, 9), Adam10, and SIRT1 were purchased from Abcam, Cambridge, MA, USA. Antibodies against pGSK3β, α-synuclein, KF-κB, LC3-1, p62, and AMPK were obtained from Cell Signaling Technology, Danvers, MA). Antibodies against IRS-1, LAMP8, and Ub1 were purchased from Santa Cruz Biotechnology, Santa Cruz, CA. GAPDH was used as an internal control (Abcam, Cambridge, MA, USA). All other chemicals were purchased from Sigma-Aldrich (St-Louis, MO, USA). The immunoreactive bands were visualized with an enhanced chemiluminescence reagent. Aβ conformation antibodies A11 and M78 were a generous gift from Dr. Charles Glabe of UC Irvine. Western blot images were quantified using image ISO lite software
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.